2007:Kari Alitalo - University of Helsinki - FinlandTargeting VEGFR-3 for the treatment of vascular complications in diabetes Hans-Peter Hammes - University of Heidelberg - Mannheim, Germany Treating diabetic retinopathy with carnosine Fredrik Leeb-Lundberg - Lund University - Sweden Metabolic and vascular consequences of signalling through the G protein-coupled estrogen receptor GPR30 Paula Moreira - University of Coimbra - Portugal Exploring the crosstalk between mitochondrial reactive oxygen species and the transcriptional factor hypoxia factor-1 in brain and retinal endothelium 2006:Zoltán Benyó - Ruprecht-Karls-University - Heidelberg, GermanyG protein mediated signalling pathways and vascular NADPH oxidases in the development of diabetes-induced cerebrovascular dysfunction Rakesh Chibber - King's College - London, UK Cross talk between TNF-alpha, NADPH oxidase, PKCß2, and core 2 G1cNAc-T in diabetic leukocytes Per-Anders Jansson - Göteburg University - Sweden The effect of selective PDE-5 inhibition on capillary recruitment, glucose uptake and endothelial function in insulin resistance Åke Sjöholm - Karolinska Institutet - Sweden GLP-1 regulation and signalling in normal and diabetic human endothelial cell neogenesis, apoptosis and transdifferentiation: implications for prevention of macroangiopathy in type 2 diabetes Vincenzo Trischitta - Mendel Institute - Rome, Italy TRB3 and cardiovascular risk in type 2 diabetes mellitus 2005:Massimo Federici - Tor Vegata University - Rome, ItalyThe Timp3/Tace dyad modulates insulin sensitivity and vascular inflammation: a new approach for treatment of diabetes vascular complications Luigi Gnudi - King's College - London, UK Modulation of Angiopoietin-1 and VEGF expression in the glomerulus: role in the maintenance of glomerular capillary integrity in diabetes 2004:Matthias Meier - Hannover Madical School - Hannover, GermanyProtein Kinase-C Knock-Out in Experimental Diabetic Nephropathy Giuseppe Pugliese - Rome University - Rome, Italy Role of oxidative stress in diabetic nephropathy: the p66Shc adaptor protein as amolecular target of therapeutic inervention Csaba Szabo - Semmelweis University - Budapest, Hungary Poly (ADP-ribose) polymerase and diabetic cardiovascular complications Carsten Tschöpe - Charité University - Berlin, Germany Effect of human apo A-I gene transfer on endothelial dysfunction of the resistance vessels in the periphery and on ventricular dysfunction in a rat model of diabetes mellitus type 2 2003:Christer Betsholtz - Göteborg University - Göteborg, SwedenRole of pericytes in the pathogenesis of diabetic retinopathy and nephropathy Hans-Peter Hammes - Mannheim University Hospital - Mannheim, Germany A transgenic mouse with continuous endothelial activation as a model of diabetic retinopathy Giovanni E. Mann - King's College - London, United Kingdom Role of the transcription factor Nrf2 in metabolic and hemodynamic induced antioxidant gene expression in diabetic nephropathy Katia Vancompernolle - Ghent University - Ghent, Belgium Identification and study of specific intracellular methylglyoxal-derived Advanced Glycation Endproducts that play a role in the dysfunction of endothelium under hyperglycemic conditions in diabetes 2002:Luigi Gnudi - King's College - London, United KingdomAngiopoietin-1 overexpression in the glomeruli: potential role in the maintenance of the glomerular capillary integrity in diabetes Peter Grant - Leeds University - Leeds, United Kingdom Do genetic variants of HNF1alpha explain the genetic pleiotropy between insulin resistance and coagulation? Paolo Madeddu - INBB National Laboratory - Sassari, Italy Rescue of type 2 diabetes-related impairment of limb microcirculation by angiogenesis gene therapy with human tissue Kallikrein and Akt Kinase Matthias Meier - Hannover Madical School - Hannover, Germany In-vivo study of isoforn-deficient Protein-kinase-C activation in an experimental mouse model of diabetic nephropathy |